Healthcare · Vaccine antigens production

Vaccine antigens production in Japan in 2026

Japan produces no vaccine antigens on an industrial scale — the figure stands at 30 million doses million doses in 2026. This stems from a historic shift: after several high-profile adverse events in the 1990s, Japan tightened vaccine regulations dramatically, opting to import finished products from Europe and the US. Instead of antigen production, Japan focuses on developing innovative adjuvants and delivery systems, where it leads globally. The country ranks 9th out of 197 worldwide.

Data for 2026 · unit: million doses
Position

Japan world ranking

#9 / 197

Country position on the scale from last to first place for this indicator.

JP
#9
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
5
1990
2
2000
30
2010
50
2020
30
2025
30
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Japan — how much?
Based on 2026 data — 30 million doses. This is rank #9 out of 197 countries.
What is Japan's rank by Vaccine antigens production?
Japan ranks #9 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Japan?
Over the available period the indicator changed from 1 to 30 million doses.